depo-subQ provera 104 Pfizer Inc. - Treatment for Prevention of Pregnancy
depo-subQ provera 104 (104 mg/0.65 mL) is a lower dose, subcutaneous formulation of Depo Provera indicated for the prevention of pregnancy in women of child bearing potential.Posted: December 2004
depo-subQ provera 104 (medroxyprogesterone acetate) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.
